Ahu Yuan

Ahu Yuan


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2018 in ACS Nano
Verified
Journal Article
Closed access
LMLingtong Meng
Lingtong Meng
YCYali Cheng
Yali Cheng
XTXiaoning Tong
Xiaoning Tong
SGShaoju Gan
Shaoju Gan
YDYawen Ding
Yawen Ding
AYAhu Yuan
Ahu Yuan

8 January 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
ZHZhusheng Huang
Zhusheng Huang
YWYuxiang Wang
Yuxiang Wang
DYDan Yao
Dan Yao
JWJinhui Wu
Jinhui Wu
YHYiqiao Hu
Yiqiao Hu
AYAhu Yuan
Ahu Yuan
Radiation therapy can potentially induce immunogenic cell death, thereby priming anti-tumor adaptive immune responses. However, radiation-induced systemic immune responses are very rare and insufficient to meet clinical needs. Here, we demonstrate a synergetic strategy for boosting radiation-induced immunogenic cell death by constructing gadolinium-hemin based nanoscale coordination polymers to simultaneously perform X-ray deposition and glutathione depletion. Subsequently, immunogenic cell death is induced by sensitized radiation to potentiate checkpoint blockade immunotherapies against primary and metastatic tumors. In conclusion, nanoscale coordination polymers-sensitized radiation therapy exhibits biocompatibility and therapeutic efficacy in preclinical cancer models, and has the potential for further application in cancer radio-immunotherapy.

1 September 2017 in Acta Biomaterialia
Verified
Journal Article
Closed access
HRHao Ren
Hao Ren
JLJiaqi Liu
Jiaqi Liu
YLYuqin Li
Yuqin Li
HWHaoran Wang
Haoran Wang
SGSizhan Ge
Sizhan Ge
JWJinhui Wu
Jinhui Wu

16 August 2019 in Advanced Functional Materials
Verified
Journal Article
Closed access
PDF file
SGShaoju Gan
Shaoju Gan
XTXiaoning Tong
Xiaoning Tong
YZYue Zhang
Yue Zhang
JWJinhui Wu
Jinhui Wu
YHYiqiao Hu
Yiqiao Hu
AYAhu Yuan
Ahu Yuan

5 April 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
WWWenguang Wang
Wenguang Wang
YCYuhao Cheng
Yuhao Cheng
PYPeng Yu
Peng Yu
HWHaoran Wang
Haoran Wang
YZYue Zhang
Yue Zhang
JWJinhui Wu
Jinhui Wu
Hypoxia-based agents (HBAs), such as anaerobic bacteria and bioreductive prodrugs, require both a permeable and hypoxic intratumoural environment to be fully effective. To solve this problem, herein, we report that perfluorocarbon nanoparticles (PNPs) can be used to create a long-lasting, penetrable and hypoxic tumour microenvironment for ensuring both the delivery and activation of subsequently administered HBAs. In addition to the increased permeability and enhanced hypoxia caused by the PNPs, the PNPs can be retained to further achieve the long-term inhibition of intratumoural O2reperfusion while enhancing HBA accumulation for over 24 h. Therefore, perfluorocarbon materials may have great potential for reigniting clinical research on hypoxia-based drugs.

3 May 2021 in ACS Nano
Verified
Journal Article
Closed access
ZHZhusheng Huang
Zhusheng Huang
DYDan Yao
Dan Yao
QYQingsong Ye
Qingsong Ye
HJHaojie Jiang
Haojie Jiang
RGRong Gu
Rong Gu
AYAhu Yuan
Ahu Yuan